SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Truncating SLC5A7 mutations underlie a spectrum of dominant hereditary motor neuropathies.

Salter, CG; Beijer, D; Hardy, H; Barwick, KES; Bower, M; Mademan, I; De Jonghe, P; Deconinck, T; Russell, MA; McEntagart, MM; et al. Salter, CG; Beijer, D; Hardy, H; Barwick, KES; Bower, M; Mademan, I; De Jonghe, P; Deconinck, T; Russell, MA; McEntagart, MM; Chioza, BA; Blakely, RD; Chilton, JK; De Bleecker, J; Baets, J; Baple, EL; Walk, D; Crosby, AH (2018) Truncating SLC5A7 mutations underlie a spectrum of dominant hereditary motor neuropathies. Neurol Genet, 4 (2). e222. ISSN 2376-7839 https://doi.org/10.1212/NXG.0000000000000222
SGUL Authors: McEntagart, Meriel

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (498kB) | Preview

Abstract

Objective: To identify the genetic cause of disease in 2 previously unreported families with forms of distal hereditary motor neuropathies (dHMNs). Methods: The first family comprises individuals affected by dHMN type V, which lacks the cardinal clinical feature of vocal cord paralysis characteristic of dHMN-VII observed in the second family. Next-generation sequencing was performed on the proband of each family. Variants were annotated and filtered, initially focusing on genes associated with neuropathy. Candidate variants were further investigated and confirmed by dideoxy sequence analysis and cosegregation studies. Thorough patient phenotyping was completed, comprising clinical history, examination, and neurologic investigation. Results: dHMNs are a heterogeneous group of peripheral motor neuron disorders characterized by length-dependent neuropathy and progressive distal limb muscle weakness and wasting. We previously reported a dominant-negative frameshift mutation located in the concluding exon of the SLC5A7 gene encoding the choline transporter (CHT), leading to protein truncation, as the likely cause of dominantly-inherited dHMN-VII in an extended UK family. In this study, our genetic studies identified distinct heterozygous frameshift mutations located in the last coding exon of SLC5A7, predicted to result in the truncation of the CHT C-terminus, as the likely cause of the condition in each family. Conclusions: This study corroborates C-terminal CHT truncation as a cause of autosomal dominant dHMN, confirming upper limb predominating over lower limb involvement, and broadening the clinical spectrum arising from CHT malfunction.

Item Type: Article
Additional Information: Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution License 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Journal or Publication Title: Neurol Genet
ISSN: 2376-7839
Language: eng
Dates:
DateEvent
April 2018Published
23 March 2018Published Online
15 November 2017Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
2012-305121Seventh Framework Programmehttp://dx.doi.org/10.13039/501100004963
G1002279Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
PubMed ID: 29582019
Web of Science ID: WOS:000430503200001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/109826
Publisher's version: https://doi.org/10.1212/NXG.0000000000000222

Actions (login required)

Edit Item Edit Item